Ironwood Pharmaceuticals (IRWD) Treasury Shares (2010 - 2025)

Ironwood Pharmaceuticals (IRWD) has 15 years of Treasury Shares data on file, last reported at $1.6 million in Q4 2025.

• For the quarter ending Q4 2025, Treasury Shares rose 47.73% year-over-year to $1.6 million; the trailing twelve-month figure through Dec 2025 stood at $1.6 million (up 47.73% YoY), and the FY2025 full-year result was $5.4 million, up 390.46% from the prior year.
• Treasury Shares rose to $1.6 million in Q4 2025, from $1.1 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $4.3 million in Q4 2022 to a low of $1.1 million in Q4 2024.
• A 5-year average of $2.5 million and a median of $1.7 million in 2023 frame the typical range for Treasury Shares.
• Across the five-year window, Treasury Shares surged 559.23% in 2021 and tumbled 61.46% in 2023, its largest moves.
• Tracing IRWD's Treasury Shares over 5 years: stood at $3.9 million in 2021, then gained by 11.03% to $4.3 million in 2022, then plunged by 61.46% to $1.7 million in 2023, then tumbled by 32.95% to $1.1 million in 2024, then soared by 47.73% to $1.6 million in 2025.
• Business Quant data shows IRWD's Treasury Shares at $1.6 million in Q4 2025, $1.1 million in Q4 2024, and $1.7 million in Q4 2023.